SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NickD who wrote (538)2/18/2000 1:15:00 PM
From: Mike McFarland   of 675
 
< What's your take on the Bayer, Allergan, and ALGO collaborations>

Means that cnsi passes the science sniff test
and in pretty good financial shape. My guess is
that one way to get in trouble in biotech is to
jump on something that is flying, but doesn't
yet have R&D partners and such...so cnsi seems
relatively safe to me. I know momentum is the
way to play these days, but cnsi will get their
day.

I haven't done badly bottomfishing this way,
when biotech was flat for much of last year it
didn't do much for me, but obviously when biotech
is hot the stocks which have previously been beaten
down, and since fallen off everybody's radar give
the best bang for the buck. Third tier has certainly
outperformed this year so far.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News